Dexamfetamine, a scheduled stimulant substance, is employed in Australia primarily for the management of hyperkinetic disorder and, less frequently , narcolepsy. Its availability is strictly governed under the legal framework, requiring a registered medical prescription. People seeking dexamfetamine must be aware of its potential for abuse and the